These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 992695)

  • 1. [Humoral and cellular immune phenomena in pseudo-lupus-erythematosus (proceedings)].
    Schuff-Werner P; Berg PA
    Immun Infekt; 1976 Oct; 4(5):238-40. PubMed ID: 992695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoimmune phenomena and pseudo-lupus-erythematosus caused by varicose vein medications (proceedings)].
    Schwarz JA; Jost H; Welke S
    Immun Infekt; 1976 Oct; 4(5):236-8. PubMed ID: 992694
    [No Abstract]   [Full Text] [Related]  

  • 3. [Candidiasis in pseudo-lupus-erythematosus and observations on the induction of pseudo-lupus-erythematosus by drugs (proceedings)].
    Sennekamp J; Niese D
    Immun Infekt; 1976 Oct; 4(5):240-1. PubMed ID: 992696
    [No Abstract]   [Full Text] [Related]  

  • 4. [[Pseudo-LE syndrome after treatment with Venopyronum dragees] (author's transl)].
    Schwarz JA; Jost H
    Dtsch Med Wochenschr; 1975 Aug; 100(31):1590-4. PubMed ID: 1097230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of antimitochondrial antibodies in guinea pigs after oral application of Venopyronum tablets. Radioimmunoassay of antimitochondrial antibodies of the pseudo-lupus-erythematosus type, preliminary communication (proceedings)].
    Genth E; Stenzel K; Brude E; Hartl W
    Immun Infekt; 1976 Oct; 4(5):242-4. PubMed ID: 992697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pseudolupus: a severe side effect of a varicose vein drug?].
    Müller-Schoop JW; Grob PJ; Joller-Jemelka HI; Guggisberg HE
    Schweiz Med Wochenschr; 1975 May; 105(21):665-8. PubMed ID: 1215868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudolupus induced by a vasculotropic drug (author's transl)].
    Guardia J; Richart C; Martinez Vàzquez JM; Martin C
    Nouv Presse Med; 1977 Oct; 6(32):2873-5. PubMed ID: 917804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Humoral and cellular phenomena after intake of Venopyronum-dragées (pseudo-LE-syndrome)].
    Schwarz JA; Jost H; Simon A; Hagenthau C; Hufnagl HD; Keller HE
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1829-33. PubMed ID: 1030118
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the question of drug-induced pseudo-LE syndrome: preliminary results in 58 cases (author's transl)].
    Maas D; Schubothe H; Sennekamp J; Genth E; Maerker-Alzer G; Droese M; Hartl PW; Schumacher K
    Dtsch Med Wochenschr; 1975 Jul; 100(30):1555-7. PubMed ID: 1157651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced pseudolupus.
    Grob PJ; Müller-Schoop JW; Häcki MA; Joller-Jemelka HI
    Lancet; 1975 Jul; 2(7926):144-8. PubMed ID: 49743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudo-LE-syndrome caused by Venopyronum dragees].
    Flenker I; Sennekamp J; Ricken D
    Med Welt; 1976 Dec; 27(52-53):2511-2. PubMed ID: 1011984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lupus erythematosus-like syndrome with antimitochondrial antibodies. Report on 21 cases].
    Maas D; Merz KP; Hahn J; Schubothe H
    Verh Dtsch Ges Inn Med; 1972; 78():895-8. PubMed ID: 4665775
    [No Abstract]   [Full Text] [Related]  

  • 13. [Unusual clinical forms of pseudo-LE syndrome: an induced immune-complex disease? (author's transl)].
    Maintz J; Henningsen B; Buchholz K; Harders H
    Dtsch Med Wochenschr; 1975 Jul; 100(30):1558-63, 1571-2. PubMed ID: 125641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses.
    Homberg JC; Rizzetto M; Doniach D
    Clin Exp Immunol; 1974 Aug; 17(4):617-28. PubMed ID: 4466618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A syndrome similar to that of lupus erythematosus with anti-mitochondrial antibodies].
    Mass D; Schubothe H
    Minerva Med; 1973 Aug; 64(58):3009-20. PubMed ID: 4742640
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus.
    Burlingame RW
    Clin Lab Med; 1997 Sep; 17(3):367-78. PubMed ID: 9316764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the spontaneous humoral immunity reactions to collagen type I in systemic lupus erythematosus patients].
    Nesvizhskiĭ IuV; Solov'ev SK; Panasiuk AF
    Ter Arkh; 1986; 58(12):84-7. PubMed ID: 3824222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is a pseudo-LE-syndrome?].
    Hofmeister A
    Med Welt; 1983 Dec; 34(48):1363-4. PubMed ID: 6606754
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of T and B lymphocytes in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(4):505-12. PubMed ID: 788057
    [No Abstract]   [Full Text] [Related]  

  • 20. [Genetic aspects of humoral immunity reactions to collagen in man and animals. III. An analysis of the sexual dimorphism of the levels of autoantibodies to collagen type I in systemic lupus erythematosus patients and their modifications in ontogeny].
    Lil'in ET; Nesvizhskiĭ IuV; Folomeev MIu
    Genetika; 1986 Jan; 22(1):153-7. PubMed ID: 3949156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.